URIVOID (Bethanechol (25mg))

Urivoid Tablet is indicated for managing urinary retention, a condition characterized by the inability to urinate, often arising post-surgery or after childbirth. This medication assists in the contraction of bladder muscles, facilitating the process of urination. It is important to adhere to the prescribed dosage and duration provided by your healthcare provider. Urivoid can be administered on an empty stomach, but it is advisable to take it consistently at the same time each day. Discontinuing the medication without prior consultation with a physician may result in worsening symptoms, so it is crucial to follow your doctor’s advice regarding treatment duration. Generally, Urivoid Tablet is well tolerated among users, with only a few experiencing side effects. In rare instances, some individuals may notice mild effects, including stomach cramps, feelings of nausea, belching, diarrhea, heightened bowel sounds, excessive salivation, or an increased feeling of urgency to urinate. Should these effects persist, escalate, or become bothersome, it is essential to seek medical advice. Additionally, anyone considering this treatment should inform their healthcare provider of any ongoing medications or pre-existing conditions to avoid potential interactions. Pregnant patients should also discuss their situation with their doctor before starting Urivoid Tablet. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.